TY - JOUR
T1 - Enhancing convolutional neural network predictions of electrocardiograms with left ventricular dysfunction using a novel sub-waveform representation
AU - Honarvar, Hossein
AU - Agarwal, Chirag
AU - Somani, Sulaiman
AU - Vaid, Akhil
AU - Lampert, Joshua
AU - Wanyan, Tingyi
AU - Reddy, Vivek Y.
AU - Nadkarni, Girish N.
AU - Miotto, Riccardo
AU - Zitnik, Marinka
AU - Wang, Fei
AU - Glicksberg, Benjamin S.
N1 - Funding Information:
B.S.G. has received consulting fees from Anthem AI and consulting and advisory fees from Prometheus Biosciences. G.N.N. has received consulting fees from AstraZeneca, Reata, BioVie, Siemens Healthineers and GLG Consulting; grant funding from Goldfinch Bio and Renalytix; financial compensation as a scientific board member and adviser to Renalytix; owns equity in Renalytix and Pensieve Health as a cofounder and is on the advisory board of Neurona Health. The other authors declare no competing interests.
Funding Information:
This study was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) U54 TR001433-05. F.W. would also like to acknowledge the support from National Science Foundation ( NSF 1750326 and NIH RF1AG072449).
Funding Information:
We acknowledge Jay Havaldar, Mark Shervy, and Manbir Singh for IT support. We thank Eddye Golden, Shelly Kaur, and Yovanna Roa for administrative and project management support. This study was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) U54 TR001433-05. F.W. would also like to acknowledge the support from National Science Foundation (NSF 1750326 and NIH RF1AG072449). B.S.G. has received consulting fees from Anthem AI and consulting and advisory fees from Prometheus Biosciences. G.N.N. has received consulting fees from AstraZeneca, Reata, BioVie, Siemens Healthineers and GLG Consulting; grant funding from Goldfinch Bio and Renalytix; financial compensation as a scientific board member and adviser to Renalytix; owns equity in Renalytix and Pensieve Health as a cofounder and is on the advisory board of Neurona Health. The other authors declare no competing interests. All authors attest they meet the current ICMJE criteria for authorship. All clinical data were de-identified and written informed consent was waived. This study has been approved by the institutional review board at the Icahn School of Medicine at Mount Sinai.
Publisher Copyright:
© 2022 Heart Rhythm Society
PY - 2022/10
Y1 - 2022/10
N2 - Background: Electrocardiogram (ECG) deep learning (DL) has promise to improve the outcomes of patients with cardiovascular abnormalities. In ECG DL, researchers often use convolutional neural networks (CNNs) and traditionally use the full duration of raw ECG waveforms that create redundancies in feature learning and result in inaccurate predictions with large uncertainties. Objective: For enhancing these predictions, we introduced a sub-waveform representation that leverages the rhythmic pattern of ECG waveforms (data-centric approach) rather than changing the CNN architecture (model-centric approach). Results: We applied the proposed representation to a population with 92,446 patients to identify left ventricular dysfunction. We found that the sub-waveform representation increases the performance metrics compared to the full-waveform representation. We observed a 2% increase for area under the receiver operating characteristic curve and 10% increase for area under the precision-recall curve. We also carefully examined three reliability components of explainability, interpretability, and fairness. We provided an explanation for enhancements obtained by heartbeat alignment mechanism. By developing a new scoring system, we interpreted the clinical relevance of ECG features and showed that sub-waveform representation further pushes the scores towards clinical predictions. Finally, we showed that the new representation significantly reduces prediction uncertainties within subgroups that contributes to individual fairness. Conclusion: We expect that this added control over the granularity of ECG data will improve the DL modeling for new artificial intelligence technologies in the cardiovascular space.
AB - Background: Electrocardiogram (ECG) deep learning (DL) has promise to improve the outcomes of patients with cardiovascular abnormalities. In ECG DL, researchers often use convolutional neural networks (CNNs) and traditionally use the full duration of raw ECG waveforms that create redundancies in feature learning and result in inaccurate predictions with large uncertainties. Objective: For enhancing these predictions, we introduced a sub-waveform representation that leverages the rhythmic pattern of ECG waveforms (data-centric approach) rather than changing the CNN architecture (model-centric approach). Results: We applied the proposed representation to a population with 92,446 patients to identify left ventricular dysfunction. We found that the sub-waveform representation increases the performance metrics compared to the full-waveform representation. We observed a 2% increase for area under the receiver operating characteristic curve and 10% increase for area under the precision-recall curve. We also carefully examined three reliability components of explainability, interpretability, and fairness. We provided an explanation for enhancements obtained by heartbeat alignment mechanism. By developing a new scoring system, we interpreted the clinical relevance of ECG features and showed that sub-waveform representation further pushes the scores towards clinical predictions. Finally, we showed that the new representation significantly reduces prediction uncertainties within subgroups that contributes to individual fairness. Conclusion: We expect that this added control over the granularity of ECG data will improve the DL modeling for new artificial intelligence technologies in the cardiovascular space.
KW - Deep learning, Cardiology, Electrocardiograms, Sub-waveform representation, Machine Learning
UR - http://www.scopus.com/inward/record.url?scp=85139361754&partnerID=8YFLogxK
U2 - 10.1016/j.cvdhj.2022.07.074
DO - 10.1016/j.cvdhj.2022.07.074
M3 - Article
AN - SCOPUS:85139361754
VL - 3
SP - 220
EP - 231
JO - Cardiovascular Digital Health Journal
JF - Cardiovascular Digital Health Journal
SN - 2666-6936
IS - 5
ER -